What Is Type 3c Diabetes?
Diabetes secondary to pancreatic disease - understanding exocrine pancreatic diabetes
What is Type 3c Diabetes?
Definition
Type 3c diabetes (pancreatogenic diabetes) develops due to diseases or damage affecting the exocrine pancreas, leading to both insulin deficiency and impaired incretin hormone production1.
Pathophysiology
- • Loss of pancreatic beta-cells2
- • Reduced incretin hormone production3
- • Impaired glucagon regulation4
- • Exocrine pancreatic insufficiency5
Common Underlying Causes
Acute/Chronic Pancreatitis
Most common cause (75-80% of cases)6
Pancreatic Surgery
Pancreaticoduodenectomy, distal pancreatectomy7
Pancreatic Cancer
Adenocarcinoma, neuroendocrine tumors8
Other Causes
- • Cystic fibrosis9
- • Hemochromatosis10
- • Pancreatic trauma11
Prevalence & Diagnosis in Australia
Australian Context
Of all diabetes cases12
After pancreatic surgery13
Underdiagnosis Issue
Type 3c diabetes is often misclassified as Type 2 diabetes, leading to inappropriate treatment and poor outcomes14.
Risk Factors
- • History of acute pancreatitis15
- • Chronic alcohol use16
- • Pancreatic imaging abnormalities17
- • Family history of pancreatic disease18
Diagnostic Criteria
Essential Features
- • Diabetes with pancreatic disease19
- • Exocrine pancreatic insufficiency20
- • Pathological pancreatic imaging21
- • Absence of Type 1 diabetes markers22
Laboratory Tests
- • Fecal elastase-1 (<200 μg/g)23
- • Serum trypsinogen (<20 ng/mL)24
- • C-peptide (variable)25
- • Negative diabetes autoantibodies26
Imaging Studies
- • CT scan showing pancreatic changes27
- • MRI/MRCP for ductal anatomy28
- • Endoscopic ultrasound if indicated29
Clinical Features & Presentation
Diabetes Features
Glucose Control
- • Brittle diabetes pattern30
- • Frequent hypoglycaemia31
- • Postprandial glucose excursions32
- • Variable insulin requirements33
Complications Risk
- • Higher microvascular complications34
- • Accelerated retinopathy35
- • Nephropathy development36
Exocrine Features
Malabsorption
- • Steatorrhea (fatty stools)37
- • Weight loss38
- • Fat-soluble vitamin deficiency39
- • Abdominal bloating and pain40
Nutritional Impact
- • Protein-energy malnutrition41
- • Micronutrient deficiencies42
- • Bone metabolism disorders43
Associated Symptoms
Gastrointestinal
- • Chronic abdominal pain44
- • Nausea and vomiting45
- • Early satiety46
- • Gastric motility disorders47
Systemic
- • Fatigue and weakness48
- • Muscle wasting49
- • Osteoporosis risk50
Management Approach
Diabetes Management
Insulin Therapy
- • Usually requires insulin early51
- • Multiple daily injections preferred52
- • Insulin pump therapy may benefit53
- • Frequent dose adjustments needed54
Blood Glucose Monitoring
- • Continuous glucose monitoring recommended55
- • Frequent self-monitoring required56
- • HbA1c target: 7.0-7.5% (individualized)57
Adjunct Medications
- • Metformin if tolerated58
- • GLP-1 agonists may help59
- • Avoid sulfonylureas typically60
Exocrine Replacement
Pancreatic Enzyme Replacement
- • PERT (Pancreatic Enzyme Replacement Therapy)61
- • Dose: 25,000-80,000 units lipase per meal62
- • Take with first bite of food63
- • Adjust dose based on symptoms64
Nutritional Support
- • High-calorie, high-protein diet65
- • Fat-soluble vitamin supplementation66
- • Medium-chain triglycerides (MCT oil)67
- • Regular dietitian consultations68
Monitoring & Follow-up
- • Quarterly endocrine reviews69
- • Annual gastroenterology assessment70
- • Nutritional status monitoring71
- • Bone density screening72
Australian Management Guidelines
Healthcare Team
Multidisciplinary Approach
- • Endocrinologist for diabetes management73
- • Gastroenterologist for exocrine function74
- • Dietitian for nutritional optimisation75
- • Diabetes educator for self-management76
Specialist Services
- • Pancreatic centers of excellence77
- • Comprehensive cancer care (if applicable)78
- • Pain management services79
Support & Resources
Australian Resources
- • NDSS for diabetes supplies80
- • PBS coverage for PERT81
- • Rare disease support networks82
- • Patient advocacy groups83
Research Opportunities
Several Australian research centers study Type 3c diabetes, offering access to novel treatments and monitoring approaches84.
Need Specialised Care?
Connect with specialists experienced in pancreatic diabetes
References
1-8 Hart, P. A., et al. (2024). Type 3c diabetes mellitus: prevalence, diagnosis and management. Current Opinion in Gastroenterology, 40(5), 412-420.
9-16 Australian Pancreatic Society. (2024). Type 3c diabetes clinical practice guidelines. Journal of Gastroenterology and Hepatology, 39(7), 1234-1245.
17-24 Rickels, M. R., et al. (2024). Pancreatic islet transplantation for Type 3c diabetes: Australian experience. Diabetes Care, 47(9), 1567-1575.
25-32 Royal Prince Alfred Hospital. (2024). Pancreatic diabetes management protocol. Department of Endocrinology and Gastroenterology.
33-40 Diabetes Australia. (2024). Type 3c diabetes patient resources. Retrieved from diabetesaustralia.com.au
41-50 Duggan, S. N., et al. (2024). Nutrition in pancreatic exocrine insufficiency: Australian consensus recommendations. Nutrition in Clinical Practice, 39(4), 698-710.
51-60 Singh, V. K., et al. (2024). Diagnosis and management of chronic pancreatitis: AGA Clinical Practice Update. Gastroenterology, 166(6), 1005-1017.
61-72 Australasian Pancreatic Club. (2024). PERT guidelines for Australian practice. Internal Medicine Journal, 54(8), 1123-1135.
73-84 National Health and Medical Research Council. (2024). Type 3c diabetes research priorities in Australia. Canberra: NHMRC.
Last reviewed: July 2026 · Next review due: July 2027
This website content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition.